Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
14.23
-0.10 (-0.70%)
At close: Apr 23, 2026, 4:00 PM EDT
14.23
0.00 (0.00%)
After-hours: Apr 23, 2026, 4:01 PM EDT
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $1.47 billion as of April 23, 2026. Its market cap has increased by 50.28% in one year.
Market Cap
1.47B
Enterprise Value
629.19M
1-Year Change
50.28%
Ranking
Category
Stock Price
$14.23
Market Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $1.47B, an increase of 4,131.29%. That is a compound annual growth rate of 37.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 1.46B | -50.86% |
| Dec 31, 2025 | 2.97B | 95.60% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
| Jun 18, 2014 | 34.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 1.55B |
| AnaptysBio | 1.54B |
| Nanobiotix | 1.54B |
| Immunocore Holdings | 1.52B |
| Immatics | 1.51B |
| Corvus Pharmaceuticals | 1.50B |
| Ardelyx | 1.48B |
| Iovance Biotherapeutics | 1.45B |